Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Clinical and Experimental Pharmacology and Physiology

• Publication date

  2015-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1440-1681.12465PMID 26218889
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Immunosuppressant FTY720 Prolongs Survival in a Mouse Model of Diet-induced Coronary Atherosclerosis and Myocardial Infarction

  2014cited by this paper
• Circulating Monocytes Are Reduced by Sphingosine-1-Phosphate Receptor Modulators Independently of S1P3

  2013cited by this paper
• Cardiovascular effects of sphingosine-1-phosphate (S1P).

  2013cited by this paper
• Monocyte and Macrophage Heterogeneity in the Heart

  2013cited by this paper
• Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction

  2013cited by this paper
• Pre-conditioning with synthetic CpG-oligonucleotides attenuates myocardial ischemia/reperfusion injury via IL-10 up-regulation

  2013cited by this paper
• A Novel Immunomodulator, FTY-720 Reverses Existing Cardiac Hypertrophy and Fibrosis From Pressure Overload by Targeting NFAT (Nuclear Factor of Activated T-cells) Signaling and Periostin

  2013cited by this paper
• Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis

  2012cited by this paper
• Making a Difference: Monocyte Heterogeneity in Cardiovascular Disease

  2012cited by this paper
• The Sphingosine-1 Phosphate receptor agonist FTY720 dose dependently affected endothelial integrity in vitro and aggravated ventilator-induced lung injury in mice.

  2011cited by this paper
• Therapeutic siRNA silencing in inflammatory monocytes

  2011cited by this paper
• Intravenous Sphingosylphosphorylcholine Protects Ischemic and Postischemic Myocardial Tissue in a Mouse Model of Myocardial Ischemia/Reperfusion Injury

  2011cited by this paper
• Neutrophil kinetics in health and disease

  2010cited by this paper
• Pharmacological pre‐ and post‐conditioning with the sphingosine‐1‐phosphate receptor modulator FTY720 after myocardial ischaemia–reperfusion

  2010influential reference
• When monocytes come (too) close to our hearts.

  2010cited by this paper
• Angiotensin-Converting Enzyme Inhibition Prevents the Release of Monocytes From Their Splenic Reservoir in Mice With Myocardial Infarction

  2010cited by this paper
• FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.

  2010cited by this paper
• Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.

  2009cited by this paper
• Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors.

  2009cited by this paper
• Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites

  2009influential reference
• Intraperitoneal anaesthesia with propofol, medetomidine and fentanyl in mice

  2009cited by this paper
• Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.

  2009cited by this paper
• The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia.

  2009cited by this paper
• FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.

  2008cited by this paper
• Sphingosine can pre‐ and post‐condition heart and utilizes a different mechanism from sphingosine 1‐phosphate

  2008cited by this paper
• Use of Ly6G‐specific monoclonal antibody to deplete neutrophils in mice

  2008cited by this paper
• The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

  2007cited by this paper
• A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.

  2007cited by this paper
• Toll‐like receptor 4 modulates myocardial ischaemia–reperfusion injury: Role of matrix metalloproteinases

  2006cited by this paper
• Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration.

  2006cited by this paper
• MyD88 Signaling Controls Autoimmune Myocarditis Induction

  2006cited by this paper
• FTY720, A Novel Immunomodulator: Efficacy and Safety Results from the First Phase 2A Study in de novo Renal Transplantation

  2005cited by this paper
• The immune modulator FTY720 targets sphingosine–kinase‐dependent migration of human monocytes in response to amyloid beta‐protein and its precursor

  2004cited by this paper
• Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection.

  2002cited by this paper
• Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCε knockout mouse hearts

  2002cited by this paper
• Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts.

  2002cited by this paper
• The Journal of Experimental Medicine

  2000cited by this paper
• Structure of the human cyclo-oxygenase-2 gene.

  1994cited by this paper

• The novel sphingosine-1-phosphate receptor modulator KRP-203 prevents myocardial ischemia–reperfusion injury by preserving mitochondrial function through activation of the RISK and SAFE signaling pathways

  2025cites this paper
• Sphingosine‐1‐phosphate signalling in the heart: exploring emerging perspectives in cardiopathology

  2024cites this paper
• Emerging Role of Compartmentalized G Protein-Coupled Receptor Signaling in the Cardiovascular Field

  2020cites this paper
• FTY720 Protects Against Ischemia–Reperfusion Injury by Preventing the Redistribution of Tight Junction Proteins and Decreases Inflammation in the Subacute Phase in an Experimental Stroke Model

  2020cites this paper
• Sphingolipids in the Heart: From Cradle to Grave

  2020cites this paper
• Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection

  2019cites this paper
• Endothelial S1pr1 regulates pressure overload‐induced cardiac remodelling through AKT‐eNOS pathway

  2019cites this paper
• The Role of Sphingolipids in Cardiovascular Pathologies

  2018cites this paper
• Post-infarct cardiac injury, protection and repair: roles of non-cardiomyocyte multicellular and acellular components

  2018cites this paper
• Sphingosine 1 phosphate receptor-1 (S1PR1) signaling protects cardiac function by inhibiting cardiomyocyte autophagy

  2018cites this paper
• Splenectomy modulates early immuno-inflammatory responses to trauma-hemorrhage and protects mice against secondary sepsis

  2018cites this paper
• FTY720 elevates smooth muscle contraction of aorta and blood pressure in rats via ERK activation

  2017cites this paper
• Redirecting reproductive immunology research toward pregnancy as a period of temporary immune tolerance

  2017cites this paper
• Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System

  2017cites this paper
• Loss of the LIM-only protein Fhl2 impairs inflammatory reaction and scar formation after cardiac ischemia leading to better hemodynamic performance.

  2016cites this paper
• Implication of sphingosin-1-phosphate in cardiovascular regulation.

  2016cites this paper
• Splenectomy Tonsillectomy and Appendectomy-Complications and Cancer Occurrence

  2016cites this paper
• Effects of FTY720 on peripheral blood lymphocytes and graft infiltrating cells in a rat model of chronic renal allograft rejection.

  2016cites this paper
• Adoptive transfer of FTY720-treated immature bone marrow-derived dendritic cells (BMDCs) significantly reduced the spontaneous resorption rate in the CBA/J × DBA/2 mouse model

  2016cites this paper
• The role of the Secondary lymphoid organs in West Nile virus encephalitis: Immune-modifying microparticle treatment

  2015cites this paper